Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03725449 · ClinicalTrials.gov registry record · NA
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
A NA study of Melanoma and Health Status Unknown, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT03725449: Completed NA study of Melanoma and Health Status Unknown, sponsored by Rutgers, The State University of New Jersey.
NCT03725449 is a NA study of Melanoma and Health Status Unknown that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 116 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03725449, a NA study of Melanoma and Health Status Unknown, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies an internet-based intervention for skin self-examination (SSE) in participants at increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to promote regular, thorough checks on the skin in individuals at increased risk for melanoma.
Primary Outcome
Thorough SSE is defined as thoroughly examining each area of the body during the most recent SSE skin self-check in the past 2 months
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Best Practice
- BEHAVIORAL mySmartCheck
Study Locations (1)
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2018-11-03 |
| Est. Completion | 2020-08-29 |
| Phase | NA |
What the finished NCT03725449 record still lists
NCT03725449 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (84% lower).
The record links to 4 conditions, with Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT03725449 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03725449 about?
NCT03725449 is a clinical study titled "Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma". This trial studies an internet-based intervention for skin self-examination (SSE) in participants at increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to pr...
What is the current status of trial NCT03725449?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2018-11-03. Estimated completion is 2020-08-29.
What conditions does trial NCT03725449 study?
This clinical trial studies the following conditions: Melanoma, Health Status Unknown, No Evidence of Disease, Dysplastic Nevus.
What interventions are being tested in trial NCT03725449?
The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), mySmartCheck (BEHAVIORAL).
Who is sponsoring clinical trial NCT03725449?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03725449 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03725449's enrollment target sits among peer trials
116 105th of 266 higher than 162 of 266 other Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI